Tuesday, January 22, 2019

Johnson & Johnson Expects Sales Growth to Slow

Johnson & Johnson said it expects its sales growth to slow in 2019, citing pricing pressures and generic-drug competition for its pharmaceutical division.

from WSJ.com: US Business https://on.wsj.com/2Ds9I9x
via IFTTT

No comments:

Post a Comment